Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Dec 5, 2025, 4:00 PM EST
1.369
+0.019 (1.42%)
After-hours: Dec 5, 2025, 7:59 PM EST
Aptevo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 23 | 2 | 3 | 12 | 38 | 160 | |
| Market Cap Growth | 468.70% | -36.70% | -71.09% | -69.34% | -75.96% | 441.40% | |
| Enterprise Value | 6 | -0 | -10 | -0 | 6 | 163 | |
| Last Close Price | 1.35 | 86.20 | 5893.37 | 75539.28 | 256247.46 | 1193325.19 | |
| PE Ratio | - | - | - | 1.47 | - | - | |
| PS Ratio | - | - | - | 3.78 | 3.13 | 37.11 | |
| PB Ratio | 1.07 | 0.45 | 0.28 | 0.66 | 31.61 | 9.64 | |
| P/TBV Ratio | 1.31 | 0.45 | 0.28 | 0.66 | 31.61 | 9.64 | |
| EV/Sales Ratio | - | - | - | - | 0.46 | 37.90 | |
| Debt / Equity Ratio | 0.28 | 1.14 | 0.44 | 0.55 | 13.75 | 1.65 | |
| Asset Turnover | - | - | - | 0.07 | 0.22 | 0.08 | |
| Quick Ratio | 3.75 | 1.40 | 2.34 | 2.89 | 1.40 | 2.91 | |
| Current Ratio | 4.03 | 1.72 | 2.64 | 3.15 | 1.51 | 3.25 | |
| Return on Equity (ROE) | -242.74% | -284.28% | -123.53% | 73.10% | -330.24% | -217.49% | |
| Return on Assets (ROA) | -79.19% | -76.06% | -61.12% | -39.42% | -24.29% | -32.13% | |
| Return on Capital (ROIC) | -103.86% | -110.74% | -79.25% | -78.06% | -43.19% | -43.48% | |
| Return on Capital Employed (ROCE) | -124.90% | -262.20% | -163.90% | -112.30% | -98.00% | -70.50% | |
| Earnings Yield | -122.88% | -1119.01% | -511.13% | 68.12% | -74.03% | -11.10% | |
| FCF Yield | -114.80% | -1103.01% | -344.36% | -178.64% | -58.26% | -18.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.